Evidence map›Paper›PMID 26089677›Full record

Trial reportVascular health and risk management2015

Blood pressure control to prevent decline in cognition after stroke.

Hege Ihle-Hansen, Bente Thommessen, Morten W Fagerland, Anne R Øksengård, Torgeir B Wyller, Knut Engedal, Brynjar Fure

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Vascular health and risk management, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Higher blood pressure targets for hypertension in older adults.The Cochrane database of systematic reviews · 2024
    Pooled it
  2. Pooled it
  3. Blood pressure targets for hypertension in older adults.The Cochrane database of systematic reviews · 2017
    Pooled it
  4. Article
  5. Article
  6. Antihypertensive medications and dementia in older adults with hypertension.medRxiv : the preprint server for health sciences · 2024
    Article
  7. Review
  8. The effects of blood pressure on post stroke cognitive impairment: BP and PSCI.Journal of clinical hypertension (Greenwich, Conn.) · 2021
    Article
  9. Review
  10. Post-stroke dementia - a comprehensive review.BMC medicine · 2017 · on this map
    Review
  11. Hypertension and aging.Ageing research reviews · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hege Ihle-HansenDepartment of Internal Medicine, Vestre Viken Hospital Trust, Bærum Hospital, Bærum, Norway.
Bente ThommessenDepartment of Neurology, Akershus University Hospital, Lørenskog, Norway.
Morten W FagerlandOslo Centre for Biostatistics and Epidemiology, Research Support Services, Oslo University Hospital, Norway.
Anne R ØksengårdDepartment of Internal medicine, Vestre Viken Hospital Trust, Bærum Hospital, Bærum, Norway.
Torgeir B WyllerDepartment of Geriatric Medicine, Oslo University Hospital, Oslo, Norway.
Knut EngedalNorwegian Centre for Dementia Research, Oslo University Hospital, Oslo, Norway.
Brynjar FureNorwegian Knowledge Centre for the Health Services, Oslo, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTreatment of hypertension post-stroke preserves cognition through prevention of recurrent stroke, but it is not clear whether it prevents cognitive decline through other mechanisms. We aimed to describe changes in blood pressure from baseline to 1 year post-stroke and to evaluate the association between achieved blood pressure targets and cognitive function, mild cognitive impairment (MCI), and dementia.

methodsWe included patients with first-ever stroke, and defined achieved blood pressure goals as systolic blood pressure (SBP) in the categories ≤125 mmHg, ≤140 mmHg, and ≤160 mmHg, SBP reduction of ≥10 mmHg, and diastolic blood pressure (DBP) reduction of ≥5 mmHg. The main outcome variables were cognitive assessments 1 year post stroke. Secondary outcomes were diagnoses of MCI or dementia.

resultsForty-one of 166 patients (25%) reached SBP ≤125 mmHg after 1 year, 92/166 (55%) reached SBP ≤140 mmHg, and 150/166 (90%) reached SBP ≤160 mmHg. SBP was reduced by ≥10 mmHg in 44/150 (29%) and DBP by ≥5 mmHg in 57/150 (38%). We did not find any statistically significant associations between cognitive test performances and different blood pressure goals (P=0.070-1.0). Nor was there any significant association between achieved goal blood pressure or blood pressure reduction after 1 year and the diagnoses of MCI or dementia (P=0.32-0.56).

conclusionTreatment of hypertension is important for primary and secondary prevention of stroke. Showing a potential beneficial effect of blood pressure control on cognitive function, however, probably needs longer follow-up.

Indexed as

AdultAgedAged, 80 and overAntihypertensive AgentsBlood PressureCognition DisordersFemaleHumansHypertensionLinear ModelsMaleMiddle AgedNorwayPsychological TestsRisk FactorsStrokeAntihypertensive Agentscerebrovascular diseasecognitive impairmenthypertensionrisk factor managementsecondary prevention

Identifiers

PMID26089677
PMCPMC4467749

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.